Method of filling a drug capsule and article produced thereby

Information

  • Patent Grant
  • 6554818
  • Patent Number
    6,554,818
  • Date Filed
    Thursday, December 7, 2000
    23 years ago
  • Date Issued
    Tuesday, April 29, 2003
    21 years ago
Abstract
A needleless injector drug capsule assembly comprising a container, a housing therefor, a piston, and resilient seals to permit filling and sealing thereafter to maintain sterility of the contents. A seal carrier holds a seal through which filling of the capsule is carried out via its outlet orifice, and after filling the seal carrier is closed off, for example by a plug or by heat sealing.
Description




FIELD OF THE INVENTION




This invention relates to a method of filling a disposable drug capsule for assembly to a needleless injector, and to an article produced thereby.




BACKGROUND OF THE INVENTION




Needleless injectors are used as an alternative to hypodermic syringes to inject drugs through a patient's skin into the underlying tissues. A typical injector comprises a high pressure pump which dispenses a dose of liquid drug through a small hole with sufficient force to pierce the epidermis and diffuse into the tissues. This technique has been in use for over fifty years, and there are many patents covering various constructional details. A feature of practically all prior art injectors is that they are filled with drug by the user before injection: this has resulted in a number of inconvenient preparatory steps and the need to sterilize the drug chamber between each operation.




There has been a marked trend over the past twenty years to supply liquid drugs and other liquids for medical use pre-packed—for example, the familiar prefilled hypodermic syringe, or intravenous infusion bags containing a saline solution. Such presentation has several advantages: the stringent requirements for sterility are met by the manufacturer; the dosage is correct; separate vials of drug and separate syringes are not required; distribution of small quantities is facilitated; convenience and ease of use result in significant cost savings.




Needleless injectors have generally not taken advantage of these trends, and this has been a factor in the lack of widespread use of such devices. Whilst there have been attempts to use prefilled capsules, these have largely failed to address the problems and techniques associated with aseptic filling and maintaining sterility after filling. Thus, what appeared to be promising advances in the art were frustrated by the inability to aseptically fill at an economical price, and such inventions rarely progressed from laboratory prototypes.




SUMMARY OF THE INVENTION




According to the present invention there is provided a method of filling a needleless injector capsule with a drug in liquid form, and sealing the capsule after filling, the capsule defining a chamber which communicates with the exterior, prior to sealing, via an orifice in the capsule wall and an orifice in an adjacent seal held in a seal carrier, the method comprising:




(a) introducing liquid into the chamber via the seal orifice and the capsule orifice, and




(b) closing off the seal carrier to the exterior.




The invention further provides a filled and sealed drug-containing article, which comprises a needleless injector capsule defining a chamber having a drug in liquid form therein, the capsule having an orifice through a wall thereof, a seal carrier having therein a seal in which is formed an orifice communicating with the capsule orifice, and closing means for closing the seal carrier to the exterior whereby to seal off the drug in the chamber from the exterior.




A preferred embodiment comprises a hollow cylindrical capsule open at one end, and terminating in a fine hole which is the injection orifice to be placed upon the skin. A piston is slidingly and sealing located within the capsule bore adjacent to the orifice. The capsule is retained within a housing configured to connect to a needleless injector power source. Frangibly attached to the housing at the orifice end is a short tube which carries a resilient seal adapted to receive a filling needle. After filling, the filling needle is withdrawn, and a resilient plug is inserted into the short tube to form a sterile seal. During the filling process, the piston within the capsule is driven by the hydraulic pressure of the drug to some predetermined position with respect to the required fill volume. The filled capsule is then attached to the injector energy source. Before use, the frangibly connected tube is snapped off complete with the resilient seals, thus exposing the capsule orifice. The injector is then operated according to the required methodology.











BRIEF DESCRIPTION OF THE DRAWINGS




A detailed description follows, with reference to the accompanying drawings, all of which, except

FIG. 5



a


, are centre-line sectioned drawings. In the drawings:





FIG. 1

shows the capsule, housing and seal carrier assembled and empty;





FIG. 2

shows the filling needle inserted;





FIG. 3

shows the capsule filled and sealed;





FIG. 4

depicts the capsule attached to an injector energy source, and prepared for use;





FIG. 5

shows a filled and sealed capsule, sealed by an alternative sealing method;





FIG. 5



a


is an end view of what is shown in

FIG. 5

;





FIG. 6

shows a filled capsule sealed by another alternative sealing method and





FIG. 7

shows an alternate embodiment of the capsule, housing and seal carrier assembled and empty, with the sealed carrier attached to the capsule.











DETAILED DESCRIPTION OF THE INVENTION





FIG. 1

shows a capsule


2


in the form of a hollow cylindrical chamber having a small injection orifice


7


at one end and containing a resilient piston


3


located adjacent to the orifice


7


. As shown, the internal shape of the capsule


2


is preferably frusto-conical adjacent the orifice


7


to aid flow of the liquid during injection, and the piston is of a similar shape to reduce dead volume.




The assembly of capsule


2


and piston


3


is retained within a housing


1


, either by friction of by mechanical means. Housing


1


has a thread


12


or other means for attaching the assembly to a needleless injection power source. A seal carrier


8


, in the form of a short tube, is frangibly attached by a frangible connection


4


to the housing


1


, and contains a resilient seal


5


. The sealed carrier


8


may also be attached directly to the capsule


2


, as shown in FIG.


7


. Alternatively, the seal carrier


8


may be attached to housing


1


by snap fitting or other mechanical means. The resilient seal


5


has an aperture


6


therethrough which is in hydraulic connection with the orifice


7


in capsule


2


, and the cooperating faces of the capsule


2


and the seal


5


form an hydraulic seal.




Referring to

FIG. 2

, a filling needle


9


is inserted sealingly into the aperture


6


of seal


5


, and injectate


11


is forced under pressure through the orifice


7


into the capsule


2


. Hydraulic pressure forces the piston


3


along the bore of the capsule


2


to a predetermined position which represents the volume to be injected, after which the filling needle


9


is withdrawn. Filling needle


9


may have a stop


13


to control the depth of penetration of the filling needle


9


in the hole


6


of seal


5


. Stop


13


may also be a locational sliding fit within the bore of the seal carrier


8


to assist in guiding the needle


9


into aperture


6


.




After filling, a resilient plug


10


is inserted into the bore of the seal carrier


8


, as shown in FIG.


3


. Thus, the injectate


11


is sealed within the capsule by the resilient plug


10


, the resilient piston


3


, and the seal between the face of seal


5


and capsule


2


.




Preferably all the components except resilient plug


10


are supplied to the filler in a sterile condition and pre-assembled, but of course they may be supplied separately and sterilised prior to filling. The filling is preferably conducted under sterile conditions, so that any air trapped within the injectate


11


, or between seal


5


and plug


10


, is sterile. Alternatively, the completely filled assembly may be sterilized after filling by heat or radiation if appropriate.





FIG. 4

shows the filled capsule and housing attached to a needleless injector power source, and prepared for use by snapping off the seal carrier


8


together with seal


5


and plug


10


.




An alternative method of sealing the capsule after filling is shown in

FIGS. 5 and 5



a


. Seal carrier


8


is manufactured in a material which may be deformed, by the action of heat for example, and crimped together to form a seal as shown diagrammatically at


15


. The seal may be improved if the material is melted at the joint or coated with a suitable meltable sealant/adhesive. Other methods of effecting the seal include ultrasonic welding, friction welding, radiation-curing sealant, or a separate clamping component to hold the walls of seal carrier


8


in sealing contact. Thus the basic principle of sealing according to

FIG. 5

is to deform the seal carrier


8


so that the inner walls make and maintain sealing contact.




Another alternative sealing method is shown in FIG.


6


. Here, a plug


14


is sealingly inserted into the filling hole


6


of resilient seal


5


after filling.




The preferred material for the capsule is glass, and for the piston polytetrafluoroethylene (PTFE), but other combinations are suitable according to the intended application. Alternatively, the capsule may be made of the same material as the housing, and for convenience be manufactured as one component. The seal carrier is then directly attached to what is, in effect, the capsule itself. Yet another variation is for the housing to be moulded on to the capsule. In the case of a glass capsule, it is desirable to assemble it to, or mould it on, the housing soon after manufacture of the glass to prevent abrasive damage to the glass.




The procedures and components described permit a conventional syringe filling machine to be used with the minimum of modification. If small numbers of capsules are to be filled, then the filling needle


9


may be replaced by a conventional hypodermic syringe needle, and the drug may be dispensed from a syringe.




If it is required to reduce the volume of trapped air within the assembly, the air may be evacuated immediately prior to inserting the filling needle.



Claims
  • 1. A method of filling a needleless injector capsule with a drug in liquid form, and sealing the capsule after filling, the capsule defining a chamber, and a seal carrier having a seal, wherein the chamber communicates with a region exterior to the capsule, prior to sealing, via an orifice in the capsule wall and an orifice in the seal held in the seal carrier, wherein the seal is in sealing contact with the capsule wall around the orifice in the capsule wall, and wherein the capsule is retained in a housing and the seal carrier is removably attached to the housing, or the seal carrier is removably attached to the capsule, the method comprising:(a) introducing liquid into the chamber via the seal orifice and the capsule orifice, and (b) closing off the seal orifice to communication with said region by a plug inserted in the seal carrier.
  • 2. A method according to claim 1, wherein the seal carrier is frangibly attached to the housing or capsule.
  • 3. A method according to claim 1, wherein the housing is present and is moulded on to the capsule.
  • 4. A method according to claim 1, wherein the seal carrier is in the form of a tube.
  • 5. A method according to claim 1, wherein the capsule chamber has a movable piston received therein and wherein during step (a) introduction of the liquid into the chamber causes the piston to move away from the orifice in the capsule wall.
  • 6. A method of filling a needleless injector capsule with a drug in liquid form, and sealing the capsule after filling, the capsule defining a chamber, and a seal carrier having a seal, wherein the chamber communicates with a region exterior to the capsule, prior to sealing, via an orifice in the capsule wall and an orifice in the seal held in the seal carrier, wherein the seal is in sealing contact with the capsule wall around the orifice in the capsule wall, and wherein the capsule is retained in a housing and the seal carrier is removably attached to the housing, or the seal carrier is removably attached to the capsule, the method comprising:(a) introducing liquid into the chamber via the seal orifice and the capsule orifice, and (b) closing off the seal orifice to communication with said region by inserting a plug in the seal orifice.
  • 7. A method of filling a needleless injector capsule with a drug in liquid form, and sealing the capsule after filling, the capsule defining a chamber, and a seal carrier having a seal, wherein the chamber communicates with a region exterior to the capsule, prior to sealing, via an orifice in the capsule wall and an orifice in the seal held in the seal carrier, wherein the seal is in sealing contact with the capsule wall around the orifice in the capsule wall, and wherein the capsule is retained in a housing and the seal carrier is removably attached to the housing, or the seal carrier is removably attached to the capsule, the method comprising:(a) introducing liquid into the chamber via the seal orifice and the capsule orifice, and (b) closing off the seal orifice to communication with said region by deforming the seal carrier.
  • 8. A method according to claim 7, wherein the seal carrier is deformed by the action of heat.
Priority Claims (2)
Number Date Country Kind
9606904 Apr 1996 GB
9608782 Apr 1996 GB
Parent Case Info

This application is a continuation of application Ser. No 09/169,922, filed Oct. 2, 1998, which is a continuation of PCT/GB97/00889, filed Mar. 27, 1997.

US Referenced Citations (25)
Number Name Date Kind
3729031 Baldwin Apr 1973 A
3945383 Bennett et al. Mar 1976 A
4010747 Clark et al. Mar 1977 A
4227528 Wardlaw Oct 1980 A
4338980 Schwebel et al. Jul 1982 A
4351692 Ouellette Sep 1982 A
4507113 Dunlap Mar 1985 A
4518385 Lindmayer et al. May 1985 A
4568346 Van Dijk Feb 1986 A
4662878 Lindmayer May 1987 A
4898209 Zbed Feb 1990 A
5062830 Dunlop Nov 1991 A
5188615 Haber et al. Feb 1993 A
5256142 Colavecchio Oct 1993 A
5312335 McKinnon et al. May 1994 A
5499972 Parsons Mar 1996 A
5503627 McKinnon et al. Apr 1996 A
5503628 Fetters et al. Apr 1996 A
5779668 Grabenkort Jul 1998 A
5788670 Reinhard et al. Aug 1998 A
5875976 Nelson et al. Mar 1999 A
5879327 DeFarges et al. Mar 1999 A
5938637 Austin et al. Aug 1999 A
6053890 Defarges et al. Apr 2000 A
6174304 Weston Jan 2001 B1
Foreign Referenced Citations (19)
Number Date Country
0 201 638 Nov 1986 EP
0 328 504 Aug 1989 EP
0 412 621 Feb 1991 EP
0 526 772 Feb 1993 EP
0 737 484 Oct 1996 EP
A-824357 Feb 1938 FR
206 016 Aug 1990 HU
133435 Nov 1966 NL
WO 9503844 Feb 1995 WO
WO9524176 Sep 1995 WO
W09615821 May 1996 WO
WO 9619252 Jun 1996 WO
WO 9628202 Sep 1996 WO
WO 9713536 Apr 1997 WO
WO 9722375 Jun 1997 WO
WO 9736785 Oct 1997 WO
W09812121 Mar 1998 WO
WO 0015281 Mar 2000 WO
WO 0035520 Jun 2000 WO
Continuations (2)
Number Date Country
Parent 09/169922 Oct 1998 US
Child 09/732168 US
Parent PCT/GB97/00889 Mar 1997 US
Child 09/169922 US